PIK3CA and breast carcinoma: Several further studies in breast cancer cells have also shown that the presence of amplified HER2 or the dual presence of PIK3CA mutation and HER2 amplification increases sensitivity to NVP-BEZ235 and GDC-0941, potentially through an increased cell death response [133,134].